BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26614088)

  • 1. Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases.
    Hirano Y; Nakamura N; Zenda S; Hojo H; Motegi A; Arahira S; Toshima M; Onozawa M; Akimoto T
    Int J Clin Oncol; 2016 Jun; 21(3):609-14. PubMed ID: 26614088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-irradiation for painful bone metastases using stereotactic body radiotherapy.
    Ogawa H; Ito K; Shimizuguchi T; Furuya T; Nihei K; Karasawa K
    Acta Oncol; 2018 Dec; 57(12):1700-1704. PubMed ID: 30280622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and toxicity of re-irradiation spine stereotactic body radiotherapy with respect to irradiation dose history.
    Ito K; Ogawa H; Nakajima Y
    Jpn J Clin Oncol; 2021 Feb; 51(2):264-270. PubMed ID: 33020807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for neuropathic pain due to bone metastases.
    Roos DE
    Ann Palliat Med; 2015 Oct; 4(4):220-4. PubMed ID: 26541402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of patients treated with re-irradiation for spine or pelvic bone metastasis: A multi-institutional analysis of 98 patients.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Tatekawa K; Nakashima A; Takenaka T; Nishimura T; Sasaki N; Oh RJ; Konishi K; Okabe H; Nagasawa S; Yamada K
    Mol Clin Oncol; 2017 Jun; 6(6):871-875. PubMed ID: 28588780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation : Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Pontoriero A; Lillo S; Caravatta L; Bellafiore F; Longo S; Lattanzi E; Parisi S; Fiorica F; Massaccesi M
    Strahlenther Onkol; 2021 May; 197(5):369-384. PubMed ID: 33635395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiation therapy administered to a previously irradiated spine is effective and well-tolerated.
    Doi H; Tamari K; Masai N; Akino Y; Tatsumi D; Shiomi H; Oh RJ
    Clin Transl Oncol; 2021 Feb; 23(2):229-239. PubMed ID: 32504187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes increases the risk of serious adverse events after re-irradiation of the spine.
    Suppli MH; Munck Af Rosenschöld P; Pappot H; Engelholm SA
    Radiother Oncol; 2019 Jul; 136():130-135. PubMed ID: 31015114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to radiotherapy in metastatic spinal cord compression.
    Suppl MH
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Outcomes After Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single-Fraction Radiation Therapy.
    Lam TC; Uno H; Krishnan M; Lutz S; Groff M; Cheney M; Balboni T
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):373-81. PubMed ID: 26279324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifraction radiotherapy for palliation of painful bone metastases: 20 Gy versus 30 Gy.
    Valeriani M; Scaringi C; Blasi L; Carnevale A; De Sanctis V; Bonome P; Bracci S; Marrone G; Minniti G; Enrici RM
    Tumori; 2015; 101(3):318-22. PubMed ID: 25908049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative Reirradiation for Painful Bone Metastases: Clinical Cases and Literature Review.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Tatekawa K; Shimizu D; Kimoto T; Nishimura T; Nakashima A; Yamada K
    Kurume Med J; 2018 Feb; 64(1.2):5-11. PubMed ID: 29249780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
    Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
    Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.
    Chow E; Meyer RM; Ding K; Nabid A; Chabot P; Wong P; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; Brundage M; DeAngelis C; Wong RKS
    Lancet Oncol; 2015 Nov; 16(15):1463-1472. PubMed ID: 26489389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clinical data on human spinal cord re-irradiation tolerance.
    Doi H; Tamari K; Oh RJ; Nieder C
    Strahlenther Onkol; 2021 Jun; 197(6):463-473. PubMed ID: 33950265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-irradiation for painful bone metastases - a systematic review.
    Wong E; Hoskin P; Bedard G; Poon M; Zeng L; Lam H; Vulpe H; Tsao M; Pulenzas N; Chow E
    Radiother Oncol; 2014 Jan; 110(1):61-70. PubMed ID: 24094630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma.
    Kim T; Cha HJ; Kim JW; Seong J; Lee IJ
    Oncotarget; 2016 Aug; 7(33):53921-53929. PubMed ID: 27259272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.